Quick Answer
STANDARD BIOTOOLS INC. reported Research And Development Expense of $25.99 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed a decrease of -9.9% in Research And Development Expense from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2003 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2003 to 2025), STANDARD BIOTOOLS INC.'s Research And Development Expense has grown by 103,848.0%.
- Historical annual values: Fiscal year 2025: $25.99 million | Fiscal year 2024: $28.83 million | Fiscal year 2023: $25.95 million | Fiscal year 2022: $37.38 million | Fiscal year 2021: $37.94 million | Fiscal year 2020: $36.46 million | Fiscal year 2019: $31.64 million | Fiscal year 2018: $30.03 million | Fiscal year 2017: $30.83 million | Fiscal year 2016: $38.42 million | Fiscal year 2015: $39.26 million | Fiscal year 2014: $43.42 million | Fiscal year 2013: $19.95 million | Fiscal year 2012: $16.60 million | Fiscal year 2011: $13.94 million | Fiscal year 2010: $13.01 million | Fiscal year 2009: $12.32 million | Fiscal year 2003: $25.0 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: